Compare SCM & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCM | ZJYL |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Specialties |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.6M | 292.7M |
| IPO Year | 2012 | 2020 |
| Metric | SCM | ZJYL |
|---|---|---|
| Price | $9.36 | $2.31 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 195.1K | 20.7K |
| Earning Date | 05-11-2026 | 08-20-2025 |
| Dividend Yield | ★ 14.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.33 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $9.85 | $18.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.43 | $0.10 |
| 52 Week High | $15.39 | $2.86 |
| Indicator | SCM | ZJYL |
|---|---|---|
| Relative Strength Index (RSI) | 47.28 | 73.80 |
| Support Level | $9.29 | $0.57 |
| Resistance Level | $9.75 | $2.86 |
| Average True Range (ATR) | 0.33 | 0.21 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 71.66 | 88.92 |
Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.